277 related articles for article (PubMed ID: 20112371)
1. Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.
Lech M; Skuginna V; Kulkarni OP; Gong J; Wei T; Stark RW; Garlanda C; Mantovani A; Anders HJ
J Pathol; 2010 Apr; 220(5):596-607. PubMed ID: 20112371
[TBL] [Abstract][Full Text] [Related]
2. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.
Lech M; Kantner C; Kulkarni OP; Ryu M; Vlasova E; Heesemann J; Anz D; Endres S; Kobayashi KS; Flavell RA; Martin J; Anders HJ
Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872
[TBL] [Abstract][Full Text] [Related]
4. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
5. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens.
Lech M; Kulkarni OP; Pfeiffer S; Savarese E; Krug A; Garlanda C; Mantovani A; Anders HJ
J Exp Med; 2008 Aug; 205(8):1879-88. PubMed ID: 18644972
[TBL] [Abstract][Full Text] [Related]
6. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
[TBL] [Abstract][Full Text] [Related]
7. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
8. Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein.
Lech M; Avila-Ferrufino A; Allam R; Segerer S; Khandoga A; Krombach F; Garlanda C; Mantovani A; Anders HJ
J Immunol; 2009 Sep; 183(6):4109-18. PubMed ID: 19692646
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach.
Gong J; Wei T; Stark RW; Jamitzky F; Heckl WM; Anders HJ; Lech M; Rössle SC
J Struct Biol; 2010 Mar; 169(3):323-30. PubMed ID: 20025973
[TBL] [Abstract][Full Text] [Related]
10. T cell receptor V beta genes expressed by IgG anti-DNA autoantibody-inducing T cells in lupus nephritis: forbidden receptors and double-negative T cells.
Adams S; Zordan T; Sainis K; Datta S
Eur J Immunol; 1990 Jul; 20(7):1435-43. PubMed ID: 2143726
[TBL] [Abstract][Full Text] [Related]
11. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts.
Noris M; Cassis P; Azzollini N; Cavinato R; Cugini D; Casiraghi F; Aiello S; Solini S; Cassis L; Mister M; Todeschini M; Abbate M; Benigni A; Trionfini P; Tomasoni S; Mele C; Garlanda C; Polentarutti N; Mantovani A; Remuzzi G
J Immunol; 2009 Oct; 183(7):4249-60. PubMed ID: 19734209
[TBL] [Abstract][Full Text] [Related]
12. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
Drexler SK; Kong P; Inglis J; Williams RO; Garlanda C; Mantovani A; Yazdi AS; Brennan F; Feldmann M; Foxwell BM
Arthritis Rheum; 2010 Aug; 62(8):2249-61. PubMed ID: 20506350
[TBL] [Abstract][Full Text] [Related]
13. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
14. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.
Wald D; Qin J; Zhao Z; Qian Y; Naramura M; Tian L; Towne J; Sims JE; Stark GR; Li X
Nat Immunol; 2003 Sep; 4(9):920-7. PubMed ID: 12925853
[TBL] [Abstract][Full Text] [Related]
15. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
Pau E; Chang NH; Loh C; Lajoie G; Wither JE
Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
[TBL] [Abstract][Full Text] [Related]
16. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.
Tsukamoto Y; Nagai Y; Kariyone A; Shibata T; Kaisho T; Akira S; Miyake K; Takatsu K
Mol Immunol; 2009 Apr; 46(7):1278-88. PubMed ID: 19157556
[TBL] [Abstract][Full Text] [Related]
18. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs.
Hackl D; Loschko J; Sparwasser T; Reindl W; Krug AB
Eur J Immunol; 2011 May; 41(5):1334-43. PubMed ID: 21469103
[TBL] [Abstract][Full Text] [Related]
19. CD4+ T cell lines with selective patterns of autoreactivity as well as CD4- CD8- T helper cell lines augment the production of idiotypes shared by pathogenic anti-DNA autoantibodies in the NZB x SWR model of lupus nephritis.
Sainis K; Datta SK
J Immunol; 1988 Apr; 140(7):2215-24. PubMed ID: 2965184
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
